Regen BioPharma Inc
RGBPOTCHealthcare · Pharmaceutical Preparations · NV · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $236,561 | $236,560 | $236,560 | $125,517 | $61,194 | $110,000 |
| Operating income | −$338,540 | −$417,221 | −$686,950 | −$339,605 | −$200,771 | −$209,317 |
| Net income | −$1.3M | −$668,255 | $1.2M | $2.4M | −$6.8M | $3.4M |
| Total assets | $274,628 | $161,084 | $353,617 | $559,002 | $1.2M | $123,189 |
| Total liabilities | $6.6M | $5.4M | $5.5M | $8.6M | $14.7M | $7.5M |
| Equity | −$6.3M | −$5.2M | −$5.1M | −$8.0M | −$13.5M | −$7.3M |
| EPS (diluted) | $-0.05 | $-0.16 | $0.29 | $0.71 | — | — |
| Shares out. | 21.6M | 5.3M | 3.6M | 5.03B | 4.56B | 1.61B |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −143.1%
- Net margin
- −538.8%
- Return on equity
- 20.3%
- Return on assets
- −464.1%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 2387.2%
- Debt / equity
- —
- Book value / share
- $-0.29
- Revenue growth (YoY)
- 0.0%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -416.82distress
- Accruals / assets
- −324.4%clean
- Piotroski F-Score
- 4/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 3 severe● 4 warning● 3 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Q/Amissed a reporting deadline ↗May 24, 2019
- NT 10-Qmissed a reporting deadline ↗May 14, 2019
- NT 10-Kmissed a reporting deadline ↗Dec 28, 2017
- NT 10-Kmissed a reporting deadline ↗Dec 30, 2015
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Quick Capital, LlcPassive (13G)Sep 12, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| Mar 31, 2026 | 353,344 | 1.0 | -86.7% |
| Mar 13, 2026 | 2.7M | 1.0 | +21692.4% |
| Feb 27, 2026 | 12,222 | 1.0 | -57.7% |
| Feb 13, 2026 | 28,863 | 1.0 | -87.5% |
| Jan 30, 2026 | 230,524 | 1.0 | +33.5% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Unregistered equity saleMar 4, 2026
- Unregistered equity saleFeb 2, 2026
- Other material eventJan 21, 2026
- Unregistered equity saleNov 13, 2025
- Entered a material agreement · Unregistered equity sale · Other material eventOct 3, 2025
- Unregistered equity saleSep 19, 2025
- Entered a material agreement · Unregistered equity saleAug 7, 2025
- Entered a material agreement · Unregistered equity saleAug 1, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.